Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter May 2016


You'll see stronger efforts to limit opioid use for pain...due to new FDA warnings and CDC prescribing guidelines. 
   Product labeling will contain new, FDA-required boxed warnings for SHORT-acting opioids about abuse, overdose, etc...similar to those already in place for LONG-acting opioids. 
   CDC also now recommends limiting opioid doses and durations. This will lead to changes with insurers, quality measures, etc. 
   Don't let the spotlight on opioids make you shy away from appropriate pain management. And consider following these safe practices for safe use. 

If you would like to access this month's full free article on OPIOIDS from Prescriber's letter,please click here

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129  and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE